SPAGO fundamentals
Key facts
Market capitalization76.60 MSEK
Basic EPS (TTM)−0.11SEK
Founded1999
CEOMats Hansen
Websitespagonanomedical.se
About
Spagpo Nanomedical AB engages in the provision of research and development within nanomedicine. The firm focuses on the development of nanomaterials for tumor diagnostics and treatment of cancer. Its projects include SpagoPix and Tumorad. The company was founded IN 2007 and is headquartered in Lund, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−2,400.00%
−2,050.00%
−1,700.00%
−1,350.00%
−1,000.00%
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
−10.50 M
−7.00 M
−3.50 M
0.00
3.50 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
SPAGO does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company